相关实验视频
Updated: Jun 19, 2025

12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
9.2K
针对EP2/EP4可以防止cDC2s中由瘤衍生的PGE2介导的免疫抑制
Jorge Cuenca-Escalona1, Johanna Bödder1, Beatriz Subtil1
1Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein 28, 6525 GA, Nijmegen, the Netherlands.
Journal of leukocyte biology
|July 23, 2024
概括
来自瘤的前列腺素E2 (PGE2) 通过影响树突细胞 (DCs) 抑制抗瘤免疫力. 纳米颗粒封装的EP2/4对抗剂保护了DCs免受PGE2的影响,增强了抗癌免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 纳米医学是一种纳米医学.
背景情况:
- 瘤衍生的前列腺素E2 (PGE2) 抑制抗瘤免疫力,特别是通过通过EP2和EP4受体损害树突细胞 (DC) 功能.
- 准EP2/4信号显示治疗潜力,但系统性使用会引起副作用.
研究的目的:
- 评估封装在纳米颗粒 (NP) 中的EP2/4对抗剂的疗效,以保护传统的2型DCs (cDC2) 免受瘤衍生的PGE2.
- 在各种癌症模型中评估NP交付EP2/4抗剂的潜力.
主要方法:
- 在聚合物纳米粒子 (NP) 中封装EP2/4对抗剂.
- 在黑色素瘤,卵巢和结直肠癌模型中评估NP有效性,以保护cDC2s免受PGE2诱导的抑制.
- 对抑制性标记物的评估,如介白素-10的产生和调控性T细胞扩张.
主要成果:
- 来自瘤的PGE2通过EP2/4信号传递诱导cDC2s中的抑制性表型.
- NP封装的EP2/4抗剂有效地抑制了cDC2s中的这种抑制过渡.
- NP降低了互白素-10的产生和调节性T细胞扩张,这对免疫抑制至关重要.
结论:
- 用NP封装的抗剂准PGE2-EP2/4轴可以克服瘤诱导的免疫抑制.
- 这种方法有望缓解免疫抑制并增强癌症患者的抗瘤免疫力.
- 纳米颗粒的输送限制了非目标效应,提供了更安全的治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

